Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px
Organisation › Details

F-Star Biotechnology Ltd. (F-Star Therapeutics)

F-star is a clinical-stage biopharmaceutical company developing bispecific antibody immuno-oncology products selected for their potential to transform the treatment of cancer. Through the application of its highly efficient Modular Antibody Technology™ platform, F-star is the only biotechnology company able to create bispecific antibodies where the second binding site is in the constant Fc region of an antibody. The strength of the technology and programmes has been leveraged through partnerships with leading biopharmaceutical companies including AbbVie, Bristol-Myers Squibb, Merck Serono and Boehringer Ingelheim. F-star has currently one program in the clinic with a second immuno-oncology program heading toward IND. The Company has built a comprehensive IP estate around its technology and product pipeline, with over 50 patent applications filed and over 25 granted patents. F-star’s management team has a well-established track record in building successful biotech companies, and developing biologics. The team is advised by a world-leading scientific advisory board and a highly experienced board of directors. F-star has raised close to $100M in non-dilutive capital and revenues. The company currently employs over 60 people at its research site in Cambridge, UK. *

 

Period Start 2008-03-12 established
  Group Sino Biopharm (Group)
Products Industry antibody technology
  Industry 2 therapeutic antibody
Persons Person Haurum, John (F-Star 201205–201810 CEO before ImClone System + Symphogen LEFT 10/18)
  Person 2 Dancer, Jane E. (F-Star 201205– COO before Cellzome 200801– VP BusDev before CAT)
     
Region Region Babraham, Cambridgeshire
  Country United Kingdom (GB)
  Street B920 Eddeva
Babraham Research Campus
  City CB22 3AT Cambridge, Cambridgeshire
  Tel +44-1223-497400
    Address record changed: 2020-12-02
     
Basic data Employees C: 51 to 100 (2016-04-21)
     
    * Document for »About Section«: 
     
   
Record changed: 2023-07-10

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Sino Biopharm (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top